What began as childhood sore throat became a lifelong battle with chronic disease for 25-year-old Chandra Crosby.
Chandra came down with strep throat when she was eight years old. The illness is common and easily cured after a few days but not for Chandra.
Strep seemed to trigger inflammation in her legs. Soon, Chandra was in excruciating pain and couldn’t even walk.
ImmuPharma is a pharmaceutical development company listed since 2006 on AIM of the London Stock Exchange (LON: IMM), focusing on developing novel medicines with high sales potential in specialist markets with serious unmet need. ImmuPharma is led by a commercially focused Board and management team with extensive experience.